Novo Nordisk A/SNVONYSE
Loading
Year-over-year net income growth rate
Latest
33.21%
↑ 662% vs avg
Percentile
P90
Near historical high
Streak
1 qtr
Consecutive growthAccelerating
Average
4.36%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 33.21% |
| Q3 2025 | -24.51% |
| Q2 2025 | -8.72% |
| Q1 2025 | 2.85% |
| Q4 2024 | 3.40% |
| Q3 2024 | 36.16% |
| Q2 2024 | -21.08% |
| Q1 2024 | 15.68% |
| Q4 2023 | -2.29% |
| Q3 2023 | 15.70% |
| Q2 2023 | -1.95% |
| Q1 2023 | 45.78% |
| Q4 2022 | -5.64% |
| Q3 2022 | 8.16% |
| Q2 2022 | -6.28% |
| Q1 2022 | 30.46% |
| Q4 2021 | -10.12% |
| Q3 2021 | -0.03% |
| Q2 2021 | -3.96% |
| Q1 2021 | 35.47% |
| Q4 2020 | -9.52% |
| Q3 2020 | -3.08% |
| Q2 2020 | -10.69% |
| Q1 2020 | 36.48% |
| Q4 2019 | -14.49% |
| Q3 2019 | 6.24% |
| Q2 2019 | -8.14% |
| Q1 2019 | 22.93% |
| Q4 2018 | -5.98% |
| Q3 2018 | -12.63% |
| Q2 2018 | -3.79% |
| Q1 2018 | 30.27% |
| Q4 2017 | -15.53% |
| Q3 2017 | -1.82% |
| Q2 2017 | -2.02% |
| Q1 2017 | 16.75% |
| Q4 2016 | -11.26% |
| Q3 2016 | -1.66% |
| Q2 2016 | 5.43% |
| Q1 2016 | 14.50% |